InvestorsHub Logo
Followers 72
Posts 9170
Boards Moderated 0
Alias Born 09/30/2006

Re: Prominent Capital post# 25967

Thursday, 04/22/2021 10:07:30 AM

Thursday, April 22, 2021 10:07:30 AM

Post# of 36601
Correct Mindmed is far away from Revive....far behind in everything except it's pps....which is based on nothing but hype IMO, but has greatly diminished lately.

Are they even conducting any FDA Trials on their Psych portfolio or is it all Euro based?

All the while Revive has multiple ongoing Trials/IND's for Covid, CBD's, Psych Delivery Methods and Psych's themselves.

Revive is slowly, with little fanfare, building it's Psychedelic portfolio by investing/engaging in collaborative research into Delivery Systems for Treatments and securing it's own Production and Supply of Psilocybin.

?When? this Sector becomes mainstreamed for treating persons with psychological issues the company will be well positioned to take a leading role because of these actions, especially re the delivery of Psych doses....have seen only one other company doing official research in this area.

As for our current position, the only ones complaining are those who have become impatient, which I fully understand, and those who are desperate for Revive's stock to go parabolic so they can flip.

Which group do you fall under!?!

WELCOME TO UNICORNLAND